Fortitude Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,618
Closed -$216K 229
2023
Q4
$216K Sell
2,618
-213
-8% -$16.2K 0.13% 179
2023
Q3
$222K Buy
2,831
+276
+11% +$23.1K 0.15% 159
2023
Q2
$225K Sell
2,555
-85
-3% -$7.32K 0.17% 166
2023
Q1
$213K Buy
+2,640
New +$215K 0.16% 178
2022
Q2
Sell
-1,797
Closed -$200K 832
2022
Q1
$200K Buy
1,797
+286
+19% +$30.2K 0.11% 198
2021
Q4
$156K Buy
+1,511
New +$175K 0.08% 252

Other funds holding MDT

Fortitude Advisory Group's MDT Position: Q1 2024 in Review

Fortitude Advisory Group sold out of Medtronic (MDT) in Q1 2024, closing a stake of 2,618 shares — an estimated $216K sold.

Fortitude Advisory Group first reported a position in MDT in Q4 2021 and held it in 6 quarters. The position peaked at $225K in Q2 2023. 2,081 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Fortitude Advisory Group reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • Fortitude Advisory Group sold 2,618 Medtronic shares in Q1 2024, an estimated $216K.
  • Fortitude Advisory Group first reported a position in Medtronic in Q4 2021 and held it in 6 quarters.
  • Fortitude Advisory Group's Medtronic position peaked at $225K in Q2 2023.
  • 2,081 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Fortitude Advisory Group's 13F filing for Q1 2024, filed 2 May 2024.